Candee H. Teitel

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites

Marguerite A. Butler, Nicholas P. Lang, J.F. Young et al. · Pharmacogenetics · 1992 · 418 citations

Chemoprevention Strategy, Human Populations, Metabolomic Profiling +19

Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon

Robert J. Turesky, Nicholas P. Lang, Mary Ann Butler et al. · Carcinogenesis · 1991 · 342 citations

N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells

Rodney F. Minchin, P.T. Reeves, Candee H. Teitel et al. · Biochemical and Biophysical Research Communications · 1992 · 248 citations

Cos-1 Cells, Combinatorial Chemistry, Heterocyclic +8

Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression

Brian Coles, Fabrice Morel, Claudine Rauch et al. · Pharmacogenetics · 2001 · 223 citations

Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-l-methyl-6-phenyUmidazo[4,5-<i>b</i>]pyridine (PhIP) in rat extrahepatic tissues

Keith R. Kaderlik, Rodney F. Minchin, Gerard J. Mulder et al. · Carcinogenesis · 1994 · 145 citations